AI Verdict
RAVE has stronger fundamentals based on our AI analysis.
RAVE vs RAPH Fundamental Comparison
| Metric | RAVE | RAPH |
|---|---|---|
| Revenue | $6.3M | N/A |
| Net Income | $1.3M | $-1.3M |
| Net Margin | 20.5% | N/A |
| ROE | 8.3% | N/A |
| ROA | 7.3% | -2,413.2% |
| Current Ratio | 8.50x | 0.03x |
| Debt/Equity | 0.00x | N/A |
| EPS | $0.09 | $0.07 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RAVE vs RAPH: Frequently Asked Questions
Is RAVE or RAPH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RAVE has stronger fundamentals. RAVE is rated SELL (60% confidence) while RAPH is rated STRONG SELL (90% confidence). This is not investment advice.
How does RAVE compare to RAPH fundamentally?
RAVE RESTAURANT GROUP, INC. has ROE of 8.3% vs Raphael Pharmaceutical Inc.'s N/A. Net margins are 20.5% vs N/A respectively.
Which stock pays higher dividends, RAVE or RAPH?
RAVE has a dividend yield of N/A or no dividend while RAPH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RAVE or RAPH for long term?
For long-term investing, consider that RAVE has SELL rating with 60% confidence, while RAPH has STRONG SELL rating with 90% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RAVE vs RAPH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RAVE vs RAPH, the AI consensus favors RAVE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.